Sponsor pipeline

Generate Biomedicines clinical trial pipeline

Get alerts when Generate Biomedicines's trials change

5 active trials 3 recruiting 2 Phase 3 4 disease areas 4 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
3
Phase 3
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07276724 A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe… Severe Asthma Recruiting 2026-10-07
NCT07359846 A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe… Severe Asthma Recruiting 2026-10-07
Phase 1
NCT07484022 Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer Advanced Urothelial Cancer Recruiting 2026-06-18
NCT06920693 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy… Atopic Dermatitis (AD) Active, Not Recruiting 2025-12-05
NCT07116889 A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD Asthma Active, Not Recruiting 2025-11-05

Disease areas by active trials

Get alerts when Generate Biomedicines's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free